COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1486: Articles 14851-14860  | Next

Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
Gray, L. T., Raczy, M. M., Briquez, P. S., Marchell, T. M., Alpar, A. T., Wallace, R. P., Volpatti, L. R., Sasso, M. S., Cao, S., Nguyen, M., Mansurov, A., Budina, E., Watkins, E. A., Solanki, A., Mitrousis, N., Reda, J. W., Yu, S. S., Tremain, A. C., Wang, R., Nicolaescu, V., Furlong, K., Dvorkin, S., Manicassamy, B., Randall, G., Wilson, D. S., Kwissa, M., Swartz, M. A., Hubbell, J. A.
10.1101/2021.05.20.445060 — Posted: 2021-05-21
Deamidation drives molecular aging of the SARS-CoV-2 spike receptor-binding motif
Lorenzo, R., Defelipe, L. A., Aliperti, L., Niebling, S., Custodio, T. F., Löw, C., Schwarz, J. J., Remans, K., Craig, P. O., Otero, L. H., Klinke, S., Garcia-Alai, M., Sanchez, I. E., Alonso, L. G.
10.1101/2021.05.20.445042 — Posted: 2021-05-21
6',6'-Difluoro-aristeromycin is a potent inhibitor of MERS-coronavirus replication
S. Ogando, N. S., Zevenhoven-Dobbe, J., Jarhad, D., Tripathi, S. K., Lee, H. W., Jeong, L. S., Snijder, E. J., Posthuma, C. C.
10.1101/2021.05.20.445077 — Posted: 2021-05-21
Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor
Guo, H., Hu, B., Si, H.-r., Zhu, Y., Zhang, W., Li, B., Li, A., Geng, R., Lin, H.-F., Yang, X.-L., Zhou, P., Shi, Z.
10.1101/2021.05.21.445091 — Posted: 2021-05-21 Discussion: Onsite
Probenecid Inhibits SARS-CoV-2 Replication In Vivo and In Vitro
Murray, J., Hogan, R. J., Martin, D. E., Blahunka, K., Sancillo, F., Balyan, R., Lovern, M., Still, R., Tripp, R. A.
10.1101/2021.05.21.445119 — Posted: 2021-05-21
Short Telomeres and a T-Cell Shortfall in COVID-19: The Aging Effect
Anderson, J. J., Susser, E., Arbeev, K. G., Yashin, A. I., Levy, D., Verhulst, S., Aviv, A.
10.1101/2021.05.19.21257474 — Posted: 2021-05-21
A 2SIR-VD Model for Optimizing Geographical COVID-19 Vaccine Distribution in the Philippines
Almajose, A. P., White, A., Diego, C., Lazaro, R., Austriaco, N.
10.1101/2021.05.20.21257556 — Posted: 2021-05-21
Metformin Is Associated with Favorable Outcomes in Patients with COVID-19 and Type 2 Diabetes Mellitus
Ma, Z., Patel, N., Vemparala, P., Krishnamurthy, M.
10.1101/2021.05.20.21257490 — Posted: 2021-05-21
SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments
Rife Magalis, B., Mavian, C., Tagliamonte, M., Rich, S., Cash, M., Riva, A., Loeb, J. C., Norris, M., Moraga, D., Zhang, Y., Shapiro, J., Starostik, P., Marini, S., Myers, P., Ostrov, D. A., Lednicky, J. A., Morris, J. G., Lauzardo, M., Salemi, M.
10.1101/2021.05.19.21257237 — Posted: 2021-05-21
A cross-sectional study of the mismatch between telecommuting preference and frequency associated with psychological distress among Japanese workers in the COVID-19 pandemic
Otsuka, S., Ishimaru, T., Nagata, M., Tateishi, S., Eguchi, H., Tsuji, M., Ogami, A., Matsuda, S., Fujino, Y.
10.1101/2021.05.20.21257516 — Posted: 2021-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).